Cinta Moraleda
Overview
Explore the profile of Cinta Moraleda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burgos C, Mendez L, Rodriguez M, Martinez A, Sanchez P, Tovar C, et al.
Pediatr Pulmonol
. 2025 Feb;
60(3):e27495.
PMID: 40018994
Background: Despite advancements in vaccination and the transition from pandemic to endemic, SARS-CoV-2 continues to pose a medical challenge, particularly among children. In this context, imaging diagnostics, such as chest...
2.
Gastesi I, Dominguez-Rodriguez S, Le Prevost M, Ramirez A, Giaquinto C, Mesa M, et al.
Pediatr Infect Dis J
. 2025 Jan;
PMID: 39792633
In this prospective cohort study with 2326 hospitalized children and young people with coronavirus disease 2019 in Spain and Colombia, 36.4% had comorbidities. Asthma, recurrent wheezing, chronic neurological, cardiac and...
3.
Ghambi L, Rojo P, Moraleda C, Bassat Q
J Trop Pediatr
. 2025 Jan;
70(6.
PMID: 39778207
No abstract available.
4.
Conde M, Gastesi I, de Pablo L, Villanueva-Medina S, Aguilera-Alonso D, Esteban A, et al.
Children (Basel)
. 2025 Jan;
11(12.
PMID: 39767873
We evaluated the prevalence and characteristics of persistent signs and/or symptoms in children and young people (CYP) one year after hospitalization for acute COVID-19 compared with a control group of...
5.
Rojo P, Moraleda C, Giaquinto C
Clin Perinatol
. 2024 Nov;
51(4):925-933.
PMID: 39487029
The Penta Network has made significant strides in pediatric human immunodeficiency virus (HIV) research, initially focusing on clinical trials for children in Europe, before expanding globally to countries with high...
6.
Mendez-Echevarria A, Calle-Miguel L, Miralbes S, Barreiro-Perez S, Afonso-Rodriguez O, Soler-Simon J, et al.
Pediatr Infect Dis J
. 2024 Jun;
PMID: 38920379
Background: Since the end of 2023, an elevated incidence and severity of Mycoplasma pneumoniae infections among children in Asia has been noted. Subsequently, this trend was observed in several European...
7.
Velasco Puyo P, Tagarro A, Garcia-Obregon S, Villate O, Moraleda C, Huerta Aragones J, et al.
Pediatr Blood Cancer
. 2024 Jun;
71(8):e31120.
PMID: 38825724
The EPICO (Spanish general registry of COVID-19 in children)-SEHOP (Spanish Society of Pediatric Hematology and Oncology) platform gathers data from children with SARS-CoV-2 in Spain, allowing comparison between children with...
8.
Jacobs T, Mumbiro V, Cassia U, Zimba K, Nalwanga D, Ballesteros A, et al.
Clin Infect Dis
. 2023 Oct;
78(3):702-710.
PMID: 37882611
Background: We evaluated dolutegravir pharmacokinetics in infants with human immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with rifampicin-based tuberculosis (TB) treatment compared with once daily (OD) without rifampicin. Methods:...
9.
Chabala C, Jacobs T, Moraleda C, Ndaferankhande J, Mumbiro V, Passanduca A, et al.
J Pediatric Infect Dis Soc
. 2023 Oct;
12(11):581-585.
PMID: 37843384
Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values...
10.
Sperotto F, Gutierrez-Sacristan A, Makwana S, Li X, Rofeberg V, Cai T, et al.
EClinicalMedicine
. 2023 Sep;
64:102212.
PMID: 37745025
Background: Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection. It remains unclear how MIS-C phenotypes vary across SARS-CoV-2 variants. We aimed to investigate clinical characteristics...